Publication:
Elevated plasma concentrations of transforming growth factor-beta 1 in patients with unilateral ureteral obstruction

dc.contributor.buuauthorVuruşkan, Hakan
dc.contributor.buuauthorÇalışkan, Zulüf
dc.contributor.buuauthorÖzakın, Cüneyt
dc.contributor.buuauthorYavasçaoğlu, İsmet
dc.contributor.buuauthorOktay, Burçin
dc.contributor.buuauthorKordan, Yakup
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentÜroloji Bölümü
dc.contributor.departmentMikrobiyoloji Bölümü
dc.date.accessioned2021-08-16T10:55:51Z
dc.date.available2021-08-16T10:55:51Z
dc.date.issued2005-12
dc.description.abstractWe measured plasma concentrations of TGF-beta 1 in patients with obstructive ureteral calculi and compared them with the plasma concentrations of healthy volunteers. The present study was a prospective study containing a homogenous group of patients with unilateral ureteral obstruction (UUO). The study consisted of patients with ureteral stones less than 7 mm in diameter that caused mild to moderate obstruction. All patients were referred by the emergency department of our hospital and examined between April 2003 and April 2004. The presence and characteristics of both stone and obstruction were determined by plain abdominal x-ray and gray-scale ultrasonography (US). Blood samples were collected from both patients and control individuals on admission and 1 week after conservative follow-up. The plasma TGF-beta 1 concentration was determined using a quantitative sandwich enzyme immunoassay specific for TGF-beta 1. There were 35 patients with 20 women and 15 men (average age 26.8 +/- 5.9 years), and 15 volunteers in the control group, with nine women and six men (average age 24.2 +/- 4.5 years). Average stone size was 5.6 mm +/- 1.2 mm (range 3.5-7) for the patient group. US showed the presence of mild hydronephrosis in 24 and moderate hydronephrosis in 11 patients. Plasma concentrations of TGF-beta 1 in patients with ureteral obstruction (1,117 +/- 5.8 ng/ml, range 36-2,442 ng/ml) were significantly higher than those in the healthy control group (32 +/- 4 ng/ml) on admission (P < 0.001). There was a significant increase in TGF-beta 1 plasma concentrations in the patient group (33,525 +/- 6.8 ng/ml, range 1,107-73,288 ng/ml) after 1 week follow-up (P < 0.001). Ureteral obstruction increases plasma TGF-beta 1 concentrations in patients with ureteral stones as in UUO models in animal studies. A concomitant treatment with an anti-fibrotic agent may reduce the incidence of renal injury during obstruction.
dc.identifier.citationVuruskan, H. vd. (2005). "Elevated plasma concentrations of transforming growth factor-beta 1 in patients with unilateral ureteral obstruction". Urological Research, 33(6), 465-469.
dc.identifier.endpage469
dc.identifier.issn0300-5623
dc.identifier.issue6
dc.identifier.scopus2-s2.0-28844452446
dc.identifier.startpage465
dc.identifier.urihttps://doi.org/10.1007/s00240-005-0509-z
dc.identifier.urihttps://link.springer.com/article/10.1007%2Fs00240-005-0509-z
dc.identifier.urihttp://hdl.handle.net/11452/21436
dc.identifier.volume33
dc.identifier.wos000233869200011
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherSpringer
dc.relation.journalUrological Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectTGF-beta 1
dc.subjectObstructive nephropathy
dc.subjectUreteral calculus
dc.subjectInterstitial fibrosis
dc.subjectUrınary transformıng growth-factor-beta-1
dc.subjectOsteopontin expression
dc.subjectNephropathy
dc.subjectMessenger-Rna
dc.subjectKidney
dc.subjectBeta
dc.subjectRelease
dc.subjectUrology & nephrology
dc.subject.emtreeDiclofenac
dc.subject.emtreeTransforming growth factor beta1
dc.subject.emtreeAdult
dc.subject.emtreeBlood sampling
dc.subject.emtreeClinical article
dc.subject.emtreeClinical trial
dc.subject.emtreeControlled clinical trial
dc.subject.emtreeControlled study
dc.subject.emtreeEmergency ward
dc.subject.emtreeEnzyme immunoassay
dc.subject.emtreeFemale
dc.subject.emtreeFollow up
dc.subject.emtreeGray scale echography
dc.subject.emtreeHospital admission
dc.subject.emtreeHuman
dc.subject.emtreeHydronephrosis
dc.subject.emtreeMale
dc.subject.emtreePriority journal
dc.subject.emtreeQuantitative assay
dc.subject.emtreeUreter obstruction
dc.subject.emtreeUreter stone
dc.subject.emtreeX ray
dc.subject.meshAdult
dc.subject.meshAnimals
dc.subject.meshCase-control studies
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshKidney
dc.subject.meshMale
dc.subject.meshProspective studies
dc.subject.meshRenin-angiotensin system
dc.subject.meshTransforming growth factor beta
dc.subject.meshTransforming growth factor beta1
dc.subject.meshUreteral calculi
dc.subject.meshUreteral obstruction
dc.subject.scopusUreter Obstruction; Hydronephrosis; Renal Circulation
dc.subject.wosUrology & nephrology
dc.titleElevated plasma concentrations of transforming growth factor-beta 1 in patients with unilateral ureteral obstruction
dc.typeArticle
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Üroloji Bölümü
local.contributor.departmentTıp Fakültesi/Mikrobiyoloji Bölümü
local.indexed.atScopus
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: